IL10 and cancer: In particular, IL-10 inhibits cytotoxic T-cell activation by downregulating major histocompatibility complex (MHC) expression on cancer cells and antigen-presenting cells (APCs), and prevents antigen specific T cells from recognizing cancer cells [144].